A Phase I, Multi-Center, Open-Label, Single-Dose, 2 Part Study to Evaluate the Relative Bioavailability of Three Formulations in Healthy Subjects, Food Effect on Tablet Formulation in Healthy Subjects, and Pharmacokinetics of Gepotidacin (GSK2140944) in Japanese and Chinese Subjects
Phase of Trial: Phase I
Latest Information Update: 29 Nov 2017
At a glance
- Drugs Gepotidacin (Primary)
- Indications Gonorrhoea; Respiratory tract infections; Skin and soft tissue infections
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 23 Nov 2017 Status changed from active, no longer recruiting to completed.
- 27 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 08 Aug 2017 Planned End Date changed from 17 Aug 2017 to 6 Nov 2017.